Between 40 and 60 percent of people treated for a substance use disorder experience a return to substance use at some point, according to the National Institute on Drug Abuse. NIDA places that rate alongside hypertension and asthma, which reframes recurrence as a feature of chronic illness rather than a treatment failure. It also explains why the period after discharge demands deliberate clinical planning, and why Arizona relapse prevention therapy is built around it.




